Tiban M 20/500mg Tablet ER
Marketer
Ajanta Pharma Ltd
Salt Composition
Metformin (500mg) + Teneligliptin (20mg)
Overview Tiban M 20/500mg Tablet ER
Glycemic control in type 2 diabetes mellitus is achieved with Tiban M 20/500mg Extended-Release tablets, a dual-action medication. This combination therapy mitigates the risk of severe diabetic complications, including renal impairment and vision loss, and may lower the probability of cardiovascular events like stroke or myocardial infarction. Tiban M 20/500mg ER may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy requires adherence to a prescribed diet and regular physical activity. Dosage is individualized, based on your health status, glycemic readings, and other medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. This medication facilitates blood glucose management and prevents future complications. Continued adherence to your physician's dietary and exercise regimen is crucial. Lifestyle modifications are integral to diabetes management. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal distress, and headache. Concurrent use with insulin or sulfonylureas increases the risk of hypoglycemia; understanding its symptoms and management is essential. This medication is not universally suitable. Prior to initiating therapy, inform your doctor about any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions necessitate comprehensive disclosure of all medications to your physician. Alcohol should be minimized due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels will be conducted throughout treatment.
Uses of Tiban M 20/500mg Tablet ER
Managing type 2 diabetes
Major Benefits of Tiban M 20/500mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tiban M 20/500mg Extended-Release tablet whole; do not damage or alter its form. Administer this medication with a meal.
Common Side effects of Tiban M 20/500mg Tablet ER:
- Nausea
- Vomiting
- Headache
- Hypoglycemia (low blood glucose level)
- Diarrhea
How to use Tiban M 20/500mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Tibon M 20/500mg Extended-Release Tablets should be administered with a meal.
How Tiban M 20/500mg Tablet ER works:
Extended-release Tiban M tablets (20/500 mg) contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tiban M 20/500mg Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tiban M 20/500mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Tiban M 20/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tiban M 20/500mg Tablet ER on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with kidney impairment should use Tiban M 20/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. For individuals with severe kidney disease, Tiban M 20/500mg Extended-Release tablets are contraindicated. Routine kidney function monitoring is advised during treatment.
LiverUNSAFE
Extended-release Tiban M 20/500mg tablets are likely contraindicated for individuals with hepatic impairment and should be avoided. Medical advice is recommended.
What if you forget to take Tiban M 20/500mg Tablet ER :
Should you forget to take a Tiban M 20/500mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Tiban M 20/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |






